PBE ETF

PBE ETF
$96.68
See how much of PBE you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-0.16%
3 Months
+13.60%
6 Months
+10.42%
YTD
+9.82%
1 Year
+39.59%
3 Years (annualized)
+12.98%
5 Years (annualized)
+3.95%
10 Years (annualized)
+8.42%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would PBE have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
Dynamic Biotechnology & Genome Intellidex Index(^DZO)
This ETF (YTD)
+9.82%
Peer Avg (YTD)
+6.74%
vs Peers
+3.08%

PBE ETF Performance

PBE performance across multiple time periods: 1-month -0.16%, YTD 9.82%, 1-year 39.59%, 3-year 12.98%, 5-year 3.95%, 10-year 8.42%.

PBE returns outperform the peer average of 6.74% YTD. With an expense ratio of 0.58%, investors should weigh costs against performance when evaluating this ETF.

PBE vs another fund shows side-by-side returns. PBE alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-0.16%N/A
3 Months+13.60%N/A
6 Months+10.42%N/A
1 Year+39.59%N/A
3 Years+12.98%N/A
5 Years+3.95%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized